Chief Medical Officer
Dr Keohane trained as a Gastroenterologist in the UK NHS, and worked for the Medical Research Council.
He has held Project leadership and senior Management positions in Research and Development at Eli Lilly and Astrazeneca, and has been located in US, Japan, and Europe.
He joins from Glenmark Pharmaceuticals where he held the position of Chief Medical Officer.
Dr Keohane brings extensive experience in the medical assessment and worldwide development and launch of multiple novel oral, biologic, and inhaled medicines, across several Therapeutic areas including Immunology, Diabetes, Respiratory, and Neuroscience.